GG 614 GG 614 Pill - brown capsule/oblong, 16mm
Pill with imprint GG 614 GG 614 is Brown, Capsule/Oblong and has been identified as Ranitidine Hydrochloride 150 mg. It is supplied by Sandoz Pharmaceuticals Inc.
Ranitidine is used in the treatment of GERD; Erosive Esophagitis; Duodenal Ulcer; Duodenal Ulcer Prophylaxis; Cutaneous Mastocytosis and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GG 614 GG 614
Ranitidine Hydrochloride
- Imprint
- GG 614 GG 614
- Strength
- 150 mg
- Color
- Brown
- Size
- 16.00 mm
- Shape
- Capsule/Oblong
- Availability
- Rx and/or OTC
- Drug Class
- H2 antagonists
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00781-2855 (Discontinued)
- Inactive Ingredients
-
ammonia,
corn starch,
FD&C Blue No. 1,
FD&C Red No. 40,
FD&C Yellow No. 6,
gelatin,
magnesium stearate,
propylene glycol,
silicon dioxide,
sodium lauryl sulfate,
sodium starch glycolate type A potato,
titanium dioxide
Note: Inactive ingredients may vary.
Related images for "GG 614 GG 614"
More about ranitidine
- Check interactions
- Compare alternatives
- Reviews (165)
- Drug images
- Latest FDA alerts (18)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: H2 antagonists
- Breastfeeding
Patient resources
- Ranitidine drug information
- Ranitidine Tablets and Capsules
- Ranitidine Injection
- Ranitidine Suspension
- Ranitidine Syrup
Other brands
Professional resources
- Ranitidine prescribing information
- Ranitidine Capsule (FDA)
- Ranitidine Injection (FDA)
- Ranitidine Syrup (FDA)
- Ranitidine Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
